Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

R. John Simes*, Rachel L. O'Connell, Philip E. Aylward, Sergei Varshavsky, Rafael Diaz, Robert G. Wilcox, Paul W. Armstrong, Christopher B. Granger, John K. French, Frans Van de Werf, Ian C. Marschner, Rob Califf, Harvey D. White

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    24 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences